151 related articles for article (PubMed ID: 21056931)
1. Whole body MRI in type I Gaucher patients: evaluation of skeletal involvement.
Poll LW; Cox ML; Godehardt E; Steinhof V; vom Dahl S
Blood Cells Mol Dis; 2011 Jan; 46(1):53-9. PubMed ID: 21056931
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bone involvement in patients with Gaucher disease: a semi-quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi-quantitative methods used so far.
Komninaka V; Kolomodi D; Christoulas D; Marinakis T; Papatheodorou A; Repa K; Voskaridou E; Revenas K; Terpos E
Eur J Haematol; 2015 Oct; 95(4):342-51. PubMed ID: 25645321
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
[TBL] [Abstract][Full Text] [Related]
4. [Whole-body MRI in children with langerhans cell histiocytosis for the evaluation of the skeletal system].
Steinborn M; Wörtler K; Nathrath M; Schöniger M; Hahn H; Rummeny EJ
Rofo; 2008 Jul; 180(7):646-53. PubMed ID: 18561067
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance in the diagnosis of extent and osseous complications of Gaucher's disease type 1].
Roca M; Mota J; Giraldo P; Pérez Calvo J; Gómez Pereda R; Giralt M
Rev Clin Esp; 1997 Aug; 197(8):550-4. PubMed ID: 9312791
[TBL] [Abstract][Full Text] [Related]
6. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[TBL] [Abstract][Full Text] [Related]
7. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
[TBL] [Abstract][Full Text] [Related]
8. Skeletal complications of type I Gaucher disease: the magnetic resonance features.
Cremin BJ; Davey H; Goldblatt J
Clin Radiol; 1990 Apr; 41(4):244-7. PubMed ID: 2340694
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
[TBL] [Abstract][Full Text] [Related]
10. S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease.
Roca M; Mota J; Alfonso P; Pocoví M; Giraldo P
Eur J Radiol; 2007 Apr; 62(1):132-7. PubMed ID: 17161930
[TBL] [Abstract][Full Text] [Related]
11. Treatment of type 1 Gaucher's disease affecting bone with aminohydroxypropylidene bisphosphonate (pamidronate).
Ostlere L; Warner T; Meunier PJ; Hulme P; Hesp R; Watts RW; Reeve J
Q J Med; 1991 Jun; 79(290):503-15. PubMed ID: 1946931
[TBL] [Abstract][Full Text] [Related]
12. The utility of magnetic resonance imaging for bone involvement in Gaucher disease. Assessing more than bone crises.
Andrade-Campos M; Valero E; Roca M; Giraldo P;
Blood Cells Mol Dis; 2018 Feb; 68():126-134. PubMed ID: 27836527
[TBL] [Abstract][Full Text] [Related]
13. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
14. Skeletal aspects of Gaucher disease: a review.
Wenstrup RJ; Roca-Espiau M; Weinreb NJ; Bembi B
Br J Radiol; 2002; 75 Suppl 1():A2-12. PubMed ID: 12036828
[TBL] [Abstract][Full Text] [Related]
15. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
Piran S; Roberts A; Patterson MA; Amato D
Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients.
Vom Dahl S; Poll L; Di Rocco M; Ciana G; Denes C; Mariani G; Maas M
Curr Med Res Opin; 2006 Jun; 22(6):1045-64. PubMed ID: 16846538
[TBL] [Abstract][Full Text] [Related]
17. The orthopedic aspects of Gaucher disease.
Goldblatt J; Sacks S; Beighton P
Clin Orthop Relat Res; 1978; (137):208-14. PubMed ID: 743830
[TBL] [Abstract][Full Text] [Related]
18. Type I Gaucher disease with severe skeletal destruction, extraosseous extension, and monoclonal gammopathy.
Kaloterakis A; Cholongitas E; Pantelis E; Papadimitriou C; Durakis S; Filiotou A
Am J Hematol; 2004 Dec; 77(4):377-80. PubMed ID: 15551278
[TBL] [Abstract][Full Text] [Related]
19. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
20. Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density.
Baldini M; Casirati G; Ulivieri FM; Cassinerio E; Khouri Chalouhi K; Poggiali E; Borin L; Burghignoli V; Cesana BM; Cappellini MD
Blood Cells Mol Dis; 2018 Feb; 68():148-152. PubMed ID: 28693786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
